ArticleInternal medicine (Tokyo, Japan)2026
Diffusion-weighted Whole-body Imaging with Background Body Signal Suppression Enables Simultaneous Whole-body Assessments of IgG4-related Diseases.
Article in Internal medicine (Tokyo, Japan), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective IgG4-related disease (IgG4-RD) is a systemic condition that frequently involves multiple organs. This study examined the utility of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) for the diagnosis and monitoring of IgG4-RD. Methods Twenty patients underwent DWIBS for the diagnosis of IgG4-RD. Of these, six did so after steroid therapy. The extent of high-intensity areas visible on DWIBS was compared to that on computed tomography (CT). Changes in signal enhancement and apparent diffusion coefficient (ADC) values on DWIBS were analyzed following steroid therapy. Results In addition to 20 main IgG4-RD lesions, areas of high intensity were detected on DWIBS in 28 lesions in 8 organs and the retroperitoneum. The high-intensity areas on DWIBS also appeared as a mass or thickness on CT, except in three areas in the kidneys and retroperitoneum, but segmental wall thickness of the bile duct in two patients was undetectable on DWIBS. On the second DWIBS procedure following steroid therapy, all 16 high-intensity areas displayed some degree of improvement, including complete resolution (n=3), disappearance of high signal intensity and a decrease in the size of the lesion (n=6), and a decrease in both signal intensity and lesion size (n=7). Furthermore, the ADC value of 13 areas significantly increased after steroid therapy (1.32±0.24×10
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.